Treatment of genital herpes simplex virus in male patients.
Twenty-three male patients with herpes simplex virus type 2 blisters on the prepuce, glans penis, and penile shaft were divided into 2 groups. Ten patients served as controls, and thirteen patients were treated with ultrasound (1 W/cm2 for 60 sec) and Herpigon on 3 consecutive days. Results showed a negative virus culture after 3 days of treatment and significant reduction of the recurrent infection in the treated group while the control group experienced recurrent infection within 62--80 days. This method offers a new therapeutic treatment for genital herpes simplex virus.
D000328:Adult; D004338:Drug Combinations; D006561:Herpes Simplex / Q000628:therapy*; D006801:Humans; D047348:Hydrolyzable Tannins / Q000627:therapeutic use*; D008297:Male; D010409:Penile Diseases / Q000628:therapy*; D012661:Semen / Q000382:microbiology; D018139:Simplexvirus / Q000302:isolation & purification; D013634:Tannins / Q000627:therapeutic use*; D014464:Ultrasonic Therapy; D014508:Urea / Q000627:therapeutic use*; D015032:Zinc / Q000627:therapeutic use*
D004338:Drug Combinations; C024034:Herpigon; D047348:Hydrolyzable Tannins; D013634:Tannins; D014508:Urea; D015032:Zinc